Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR7109 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF397 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506639 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6727 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PIP4K2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPBP1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LUC7L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NIF3L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMSAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFATC2IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSNK1G2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP34 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRIPAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR4723 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLIPR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on